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Background: The left superior temporal gyrus (STG) has been suggested to play a key role
in auditory verbal hallucinations (AVH) in patients with schizophrenia.
Methods: Eleven medicated subjects with schizophrenia and medication-resistant AVH
and 19 healthy controls underwent perfusion magnetic resonance (MR) imaging with
arterial spin labeling (ASL). Three additional repeated measurements were conducted in
the patients. Patients underwent a treatment with transcranial magnetic stimulation (TMS)
between the first 2 measurements. The main outcome measure was the pooled cerebral
blood flow (CBF), which consisted of the regional CBF measurement in the left STG and
the global CBF measurement in the whole brain.
Results: Regional CBF in the left STG in patients was significantly higher compared to
controls (p < 0.0001) and to the global CBF in patients (p < 0.004) at baseline. Regional
CBF in the left STG remained significantly increased compared to the global CBF in
patients across time (p < 0.0007), and it remained increased in patients after TMS
compared to the baseline CBF in controls (p < 0.0001). After TMS, PANSS (p = 0.003)
and PSYRATS (p = 0.01) scores decreased significantly in patients.
Conclusions: This study demonstrated tonically increased regional CBF in the left STG in
patients with schizophrenia and auditory hallucinations despite a decrease in symptoms
after TMS. These findings were consistent with what has previously been termed a trait
marker of AVH in schizophrenia.
Keywords: schizophrenia, auditory verbal hallucinations, cerebral blood flow, arterial spin labeling, superior
temporal gyrus, longitudinal study
INTRODUCTION
In schizophrenia, auditory verbal hallucinations (AVH) comprise
a critical domain. The 1-month prevalence of these hallucina-
tions exceeds 70% (Sartorius et al., 1986), and, in 25–30% of
patients, these perceptions are resistant to medication, resulting
in functional disability and a low quality of life (Shergill et al.,
1998; Copolov et al., 2004). The development of new therapeutic
strategies (Homan et al., 2011) is urgent and would benefit from
a better understanding of the neurophysiology of AVH.
The results of resting perfusion and functional imaging stud-
ies have implied that AVH are associated with altered neuronal
activity in cerebral areas that are responsible for language produc-
tion and perception (Allen et al., 2008; Strik and Dierks, 2008).
AVH have been shown to be positively correlated with resting-
state perfusion (regional cerebral blood flow, CBF) in the medial
temporal lobe (Liddle et al., 1992), the superior temporal lobe
(Gur et al., 1995), and the anterior cingulate cortex (Lahti et al.,
2006) and negatively correlated with perfusion in the hippocam-
pus/parahippocampus (Lahti et al., 2006). In addition, when CBF
has been measured before and after interventions with tran-
scranial magnetic stimulation (TMS), it has been found to be
decreased at the stimulation site, which is the left superior tempo-
ral gyrus (STG), and in interconnected regions and increased in
the contralateral cortex and the frontal lobes after 10 days of TMS
treatment (Horacek et al., 2007). In a previous study, we found
an association of favorable TMS treatment effects and decreased
neuronal activity in the primary auditory cortex, Broca’s area,
and the cingulate gyrus (Kindler et al., 2013), suggesting that
CBF might be a biological marker for the effectiveness of TMS.
Furthermore, the CBF in the left STG before treatment predicted
the response to TMS, indicating that resting perfusion measure-
ments before treatment might be appropriate for differentiat-
ing possible responders and non-responders to TMS (Homan
et al., 2012). However, those CBF measurements were limited to
only one time point, which was before treatment, and the time
courses of the CBF and the psychopathological symptoms were
not assessed with repeated measurements. Several studies have
investigated the clinical severity of hallucinations longitudinally
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(Arndt et al., 1995; Marengo et al., 2000; Mancevski et al., 2007;
Chang et al., 2009; Schneider et al., 2011). Until now, it has been
unclear in which way the neuronal activity followed the clinical
course of AVH longitudinally in individual patients. Regions with
neuronal activity that follow the clinical course may be regarded
as state-dependent, whereas areas that demonstrate continuous
aberrant activity compared to those in non-hallucinators and
healthy subjects may be regarded as trait-specific.
In this study, we repeatedly measured CBF in a region of inter-
est (ROI) that has been previously identified (left STG, Figure 1)
to exhibit predictive CBF before TMS treatment in patients
with medication-resistant AVH (Homan et al., 2012). Patients
were treated with TMS according to a 10-day-treatment proto-
col between the first and the second measurement (Kindler et al.,
2013). Our aim was to gain insights into the fluctuations of CBF
and symptoms. In order to measure CBF, we used magnetic reso-
nance (MR) arterial spin labeling (ASL), which is a MR technique
that provides a direct quantitative measure of CBF (Horn et al.,
2009; Jann et al., 2010; Viviani et al., 2010; Walther et al., 2012).
ASL is a non-invasive technique that has been shown to provide
converging results with those that have been obtained by inva-
sive positron emission tomography perfusion imaging (Xu et al.,
2010). It thus can more easily and less invasively be applied in
situations that require repeated examinations.
In this study, we were interested in whether the proposed
responsiveness of regional CBF in the left STG to TMS (Homan
et al., 2012) was a stable (trait-like) feature over time or
whether there were fluctuations in neuronal activity across time.
Additionally, we compared the initial measurements of the series
with measurements in 19 healthy controls. Based on the results
of a recent meta-analysis that have suggested that the neuronal
activity in the left STGmight be a trait-like feature in AVH (Kuhn
and Gallinat, 2012), we hypothesized that the CBF in the left STG
would be increased compared to healthy controls and would not
change across time.
METHODS
PATIENTS AND CLINICAL INVESTIGATION
The same patient population as that described in Homan
et al. (2012) was used. However, only 11 patients were willing
FIGURE 1 | Predefined region of interest in the left superior temporal
gyrus. The local maximum peak values were retrieved from a previous
study (Homan et al., 2012); according to SPM 8, x, y, z = −58, −26, 4; x, y,
z coordinates in Talairach space.
to undergo repeated measurements after TMS treatment. The
patients who were included in the study had a diagnosis
of schizophrenia or schizoaffective disorder according to the
International Statistical Classification of Diseases and Related
Health Problems (ICD)-10, medication-resistant AVH, and ages
of 18–65 years, and they were right-handed. The right-handed
healthy control subjects had no history of any psychiatric dis-
orders and no major psychiatric conditions in their first-degree
relatives (n = 19). The exclusion criteria were MR contraindi-
cations and any medical disorders other than schizophrenia or
schizoaffective disorder in the patients. None of the subjects
reported substance misuse in the 4 weeks before or during the
study. All patients underwent identical diagnostic procedures,
including the MR protocol. The diagnostic procedures were con-
ducted based on the clinical interviews and psychiatric histories.
The psychopathology assessment, which consisted of the Positive
And Negative Syndrome Scale (PANSS) (Kay et al., 1988) and
the Psychotic Symptom Rating Scale (PSYRATS) (Haddock et al.,
1999), was performed on the same occasion as the ASL. In order
to ensure that all subjects were right-handed, the Edinburgh
Handedness Scale (Oldfield, 1971) was assessed. The investigation
was conducted in accordancewith the Declaration ofHelsinki and
was approved by the local ethics committee. All subjects provided
informed written consents to participate in the study.
STUDY PROCEDURE
Patients and controls were measured with ASL at baseline. The
psychopathology in the patients was assessed. Patients then
underwent 10 days of TMS treatment. Within 36 h after the TMS
treatment, the patients’ psychopathology and CBF with ASL were
assessed again. Patients underwent two follow-up examinations
of perfusion MRI and psychopathology 4 weeks and 8 weeks
post-TMS.
TMS PROTOCOL
The TMS protocol has been described elsewhere (Homan et al.,
2012; Kindler et al., 2013). Briefly, the target region for TMS
was the sensorimotor speech region, which is called the Sylvian
parietotemporal (Spt) area and which is located in the Sylvian
fissure at the parietotemporal boundary. We applied a modified
version of the language processing task that was developed by
Hickok et al. (2009) to localize the Spt area for TMS treatment
in a functional MR imaging (fMRI) scan of each patient in the
first MR measurement. This fMRI measurement was conducted
immediately after the ASL measurement. The individual’s fMRI
activation map was superimposed on reconstructed anatomi-
cal mesh, and the target point of the Spt area was marked
for TMS. We used a custom TMS stimulator (MagPro R 100,
Medtronic Functional Diagnostics A/S, Skovlunde, Denmark)
to generate repetitive biphasic magnetic pulses with a figure-8
coil (Magnetic Coil Transducer MC-B70, Medtronic Functional
Diagnostics A/S). The individual resting motor threshold was
identified by stimulation of the motor cortex with single TMS
pulses until a movement of the contralateral thumb was detected
(Schutter and Van Honk, 2006). TMS pulse intensity was then
adjusted to 90% of the resting motor threshold. Patients were
randomly assigned to receive 1Hz (n = 7) or theta burst (n = 4)
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TMS. The target area was stimulated for 10 consecutive days
in both groups. Common TMS safety protocols were applied
according to international safety standards (Rossi et al., 2009).
A frameless, ultrasound-based, stereotactic system was used for
neuronavigation (Brainvoyager™ TMS Neuronavigator System,
Brain Innovation B.V., Maastricht, Netherlands) (Sack et al.,
2009).
MRI DATA ANALYSIS: ASL
MRI was conducted on a 3.0-Tesla whole-body MRI system
(Magnetom Trio, Siemens Medical Systems, Erlangen, Germany)
with a standard 12-channel radiofrequency head coil. High-
resolution three-dimensional (3D) structural MRI and ASL
were acquired in each session. T1-weighted 3D magnetization
prepared-rapid gradient echo (MP-RAGE) scans were recorded
(number of slices, 176; matrix, 256 × 256; slice thickness, 1mm;
voxel size, 1 × 1 × 1mm3), and they served as high-resolution 3D
anatomical templates for coregistration with the functional data.
A pseudocontinuous ASL (pCASL) technique was used to mea-
sure CBF (Wang et al., 2005). In this gradient-echo echo-planar
imaging sequence, interleaved images with and without labeling
were acquired. A delay of 1250ms was applied between the end
of the labeling pulse (label time, 1600ms) and image acquisition
(slice acquisition time, 45ms) in order to reduce transit artifact
(field of view, 220mm2; matrix, 64 × 64; repetition time/echo
time, 4000/18ms; flip angle, 90◦; and labeling efficiency a, 0.95).
A total of 14 slices (voxel size, 3.4 × 3.4 × 6mm3; slice gap,
1.5mm) was acquired in the anterior and posterior commissure
line from inferior to superior in sequential order. The pCASL scan
comprised 80 acquisitions. The ASL data analysis was performed
in a manner that was similar to that described by Homan et al.
(2012). Briefly, we used aslm (Homan et al., 2012) (download-
able at http://aslm.sourceforge.net), which is based onMATLAB®
(MATLAB version 8, release 14; The MathWorks, Inc., Natick,
MA, USA) and statistical parametric mapping (SPM 8, Wellcome
Department of Imaging Neuroscience, London, England; www.
fil.ion.ucl.ac.uk/spm8). All ASL time series were first realigned
to correct for motion artifacts. We calculated a flow-time series
by subtracting the labeling images from the control images
and subsequently computed mean CBF images for each subject
(Federspiel et al., 2006). Each individual subjects’ T1 anatomy was
segmented into gray matter (GM) and white matter (WM). The
mean ASL images were then coregistered to the GM-segmented
T1 images. T1, GM, WM, and ASL images were normalized to
the SPM MNI T1 template. ASL images were spatially smoothed
with a 3D 8-mm full-width at half-maximum Gaussian kernel.
Data were z-transformed [z = (voxel CBF—global GM CBF)/SD]
in order to remove sources of variance that were caused by differ-
ences in the global mean CBF between acquisitions and corrected
for GM by using GM segments as inclusive masks.
STATISTICAL ANALYSIS: CBF
A global and assumption-free investigation of the whole-brain
CBF was computed. CBF values were then extracted from the
a priori-defined ROI in the left STG that corresponded to the
finding described in Homan et al. (2012) with aslm. Therefore,
the ROI was used as an inclusive mask of each subject’s ASL
measurement. The mean regional blood flow of the ROI was
calculated by taking the mean of all voxels inside the mask. A
full-factorial linear mixed model with a restricted maximum like-
lihood estimation was then computed with the pooled global and
regional CBF values of the baseline measurements as outcome
measures and diagnosis, localization (global, regional), and the
diagnosis-by-localization interaction as fixed effects. The longitu-
dinal patient data were then examined separately in full-factorial
mixed models with restricted maximum likelihood estimation
in order to examine the effects of localization, time, and med-
ication (chlorpromazine dose equivalent, CPZE) on the CBF
outcome measures. In order to additionally assess the effect of
psychopathology on CBF, PSYRATS, and PANSS were included as
additional fixed effects in these models. For the outcomemeasures
of psychopathology (PSYRATS, PANSS), the effects of time, TMS
protocol, andmedication were assessed for the first 2 observations
(pre- and post-TMS treatment). For the additional observations
(at t = 2, 3, and 4), the effects of time and medication were
assessed on the outcomemeasures of the PSYRATS and PANSS. In
order to account for the different intervals between the measure-
ments after TMS treatment, interval was also included as a fixed
effect in these longitudinal models. Furthermore, these models
included a subject effect in order to account for the repeated mea-
surements. The Schwarz Bayesian criteria were used to determine
the best fitting covariance structure for each set of measures in
cases where the typical compound symmetry approach that was
used by ANOVA did not provide the optimal structure for the
extant data. A heterogeneous variance first-order autoregressive
covariance structure proved to be appropriate for all mixed mod-
els. The post-hoc t-tests involved a Tukey correction for multiple
comparisons. SAS 9.2 (SAS Institute, Inc., Cary, NC, USA) was
used for all analyses. The means are reported with their associ-
ated standard deviations (SDs). Statistical significance was set at
p < 0.05.
RESULTS
CLINICAL DATA
Eleven patients and 19 healthy controls were measured at base-
line. Three additional repeated measurements were conducted on
the patients. The intervals between measurements differed across
the patient group (mean ± SD, 28.2 ± 32.9 days). Altogether, 44
measurements were conducted in the patients. The clinical and
demographic characteristics of the subject sample are detailed in
Table 1. The mean CPZE at baseline was 714.5 ± 475.5mg and
remained stable during the study. Between the first and second
measurement, which was after the TMS treatment, the PANSS
[F(1, 10) = 14.88, p = 0.003; Figure 2A] and PSYRATS [F(1, 10) =
9.97, p = 0.01; Figure 2B] scores were decreased significantly
in the patients. No effect of TMS stimulation mode (1Hz vs.
theta burst) was found on the PANSS [F(1, 10) = 0.18, p = 0.7]
and PSYRATS [F(1, 10) = 1.19, p = 0.3] scores, and no effect
of medication was evident. The PSYRATS score remained sta-
ble after TMS treatment across all further measurements, which
included observations at t = 2, 3, and 4 [F(2, 19) = 1.04, p =
0.37; Figure 2B]. The PANSS scores displayed a trend toward a
time effect after TMS, which included observations at t = 2, 3,
and 4, [F(2, 19) = 3.18, p = 0.06; Figure 2A].
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Table 1 | Subject characteristics of the patients (n = 11) and healthy controls (n = 19).
Characteristic Patients (n = 11) Healthy controls (n = 19) Test statistic p-value
Sex, F/M 8/3 11/8 Fisher’s exact 0.5
Diagnosis 11Sz n.a. n.a. n.a.
Age, mean (SD), y 37.1 (8.8) 38.5 (12.2) t-test 0.7
Age at onset, mean (SD), y 23.3 (4.4) n.a. n.a. n.a.
Chlorpromazine equivalent dose at study entry,
mean (SD)
714.5 (475.5) n.a. n.a. n.a.
Global mean cerebral blood flow corrected for
gray matter at study entry, mean (SD)
65.7 (7.7) 67.1 (6.2) t-test 0.6
PANSS score at study entry, mean (SD) 67.1 (18.9) n.a. n.a. n.a.
PSYRATS score at study entry, mean (SD) 35.4 (2.0) n.a. n.a. n.a.
Values are presented as means ± SD. Abbreviations: F, female; M, male; Sz, schizophrenia (according to ICD-10); n.a., not available; PANSS, Positive and Negative
Syndrome Scale; SD, standard deviation; PSYRATS, Psychotic Symptoms Rating Scale; CBF, cerebral blood flow.
FIGURE 2 | (A) Mean PANSS scores with standard errors across time in
the patients. (B) Mean PSYRATS scores with standard errors across
time in the patients. (C) Mean global and regional cerebral blood flow
(CBF) in the left superior temporal gyrus with standard error at baseline
in healthy controls and patients with schizophrenia with persistent
auditory verbal hallucinations. (D) Mean regional CBF with standard
errors in the left superior temporal gyrus across time in the patients.
The CBF values were z-transformed. ∗∗ indicates a significant difference
at p < 0.01, ∗ indicates a significant difference at p < 0.05. Abbreviations:
PANSS, Positive and Negative Syndrome Scale; PSYRATS, Psychotic
Symptoms Rating Scale; CBF, cerebral blood flow. HC, Healthy Controls;
SZ, Schizophrenia.
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GLOBAL AND REGIONAL CBF AT BASELINE
The pooled CBF (global and regional) was significantly higher
in patients with schizophrenia compared to healthy controls
[F(1, 28) = 21.19, p < 0.0001], and the regional CBF in the left
STG was significantly higher in the entire sample [F(1, 28) =
5.02, p < 0.04]. The localization-by-diagnosis interaction was
also significant [F(1, 28) = 14.74, p < 0.0007]. The post-hoc tests
revealed a significantly higher regional CBF in patients compared
to controls [t(1, 28) = 5.97, p < 0.0001, Figure 2C]. Furthermore,
regional CBF in the left STG in patients was significantly higher
compared to global CBF [t(1, 28) = 3.82, p < 0.004, Figure 2C],
an effect that was not found in healthy controls [t(1, 28) = 1.32,
p = 0.6].
LONGITUDINAL CHANGES OF GLOBAL AND REGIONAL CBF
The regional CBF in the left STG was significantly higher com-
pared to the global CBF in patients across time [F(1, 10) = 24.67,
p < 0.0007]. There was no time effect [F(3, 30) = 0.98, p = 0.4],
no effect of interval [F(1, 69) = 0.01, p = 0.9], and no time-by-
localization interaction [F(3, 30) = 0.23, p = 0.9] in the longi-
tudinal patient data (Figure 2D). In addition, no TMS effect
was evident in the left STG CBF for the first 2 measurements
[F(1, 10) = 0.1, p = 0.75]. After TMS with t = 2, 3, and 4, CBF in
the left STG of patients was still increased compared to the base-
line CBF of healthy controls [at t = 2: t(1, 28) = 5.27, p < 0.0001;
at t = 3: t(1, 28) = 3.62, p = 0.001; at t = 4: t(1, 28) = 5.3, p <
0.0001]. Furthermore, no medication effect of CPZE was evident
[F(1, 9) = 0.15, p = 0.7].
CORRELATION OF REGIONAL CBF AND PSYCHOPATHOLOGY
The regional CBF in the left STG was negatively associated with
the PSYRATS scores across time [F(1, 28) = 9.93, p = 0.004]. No
such association was found between CBF and the PANSS scores
[F(1, 28) = 1.7, p = 0.2].
DISCUSSION
Until now, longitudinal studies of global and regional CBF in
patients suffering from schizophrenia and AVH have not been
conducted. In this study, we were able to investigate patients
who were suffering from AVH several times during the course of
their disease, and we were able to demonstrate that the patients
had significantly higher CBF in a predefined region, the left
STG, compared to healthy controls and compared to global CBF.
Furthermore, the increase in regional CBF was a stable feature
across time that was unaffected by treatment with TMS.
The aim of the current study was to gain further insight into
the involvement of the left STG in AVH. Indeed, this region is
thought to play a key role in AVH interventions. Previous studies
have suggested that the left STG might be an appropriate target
region in TMS in patients with schizophrenia and AVH. Ten days
of TMS treatment to the left STG resulted in a clinically relevant
improvement of symptoms as measured by the PSYRATS, and
this has been shown to be correlated with decreases in the CBF
in primary language and auditory regions (Kindler et al., 2013)
but not with CBF changes in the STG. Furthermore, responders
and non-responders to TMS were identified by the CBF in the
left STG before treatment. One aim of the current study therefore
was to search for fluctuations in the regional CBF in the left
STG that would be consistent with the proposed responsiveness
to TMS (Homan et al., 2012). However, we did not find fluctu-
ations in the regional CBF but a persistent hyperperfusion in the
left STG during all 4 measurements compared to the baseline CBF
of healthy controls and the global CBF, suggesting that increased
regional CBF in the left STG is a trait and not a state marker
in patients with schizophrenia and AVH. This was further sup-
ported by the fact that treatment with TMS between the first and
second measurements did not alter CBF in the left STG, which
was in contrast to previous findings of decreased regional glucose
metabolism at the stimulation site in the left STG after 10 days
of TMS (Horacek et al., 2007). However, the finding of the lat-
ter study was located more anteriorly and more inferiorly (at the
temporal pole) than the ROI in the current study. Thus, the cur-
rent finding might indicate that patients who have regional CBF
values below the previously proposed cutoff value (Homan et al.,
2012) are unlikely to change to a responsive state across time.
In addition, the findings of continuously increased left STG
CBF in patients with AVH provided further evidence of the
involvement of the left STG in AVH, which has also been shown
for patients with AVH of epileptic etiology (Hauf et al., 2013). It
has been suggested that AVH arise from a disorder of inner ver-
bal experiences, particularly from a disorder of the monitoring of
inner speech (David, 1994; McGuire et al., 1995). A bottom–up
model has been proposed that includes alterations in secondary
and sometimes even primary sensory cortices, speech production
and reception areas (inferior frontal gyrus, left STG) and in the
coupling with monitoring areas (anterior cingulate) (Allen et al.,
2008). Specifically, alterations in the connectivity of the STG, the
inferior frontal gyrus, and the anterior cingulate cortex might be
the precondition for altered activity in language processing areas
(Allen et al., 2008). Thus, in the aforementioned model, AVH
are thought to be associated with decreased top–down control by
the ventral anterior cingulate, prefrontal, premotor, and cerebel-
lar cortices and failure in monitoring and volitional assignment.
Together, these alterations might be the neuronal basis of the
experience of perceptions without sensory stimuli (Allen et al.,
2008). This is in line with previous research that has focused on
the possible therapies of AVH.With regard to therapy, it is known
that low-frequency repetitive TMS that is delivered to the left tem-
poroparietal cortex, which is a brain area that is critical to speech
perception, reduces AVH (Hoffman et al., 2000, 2003; Aleman
et al., 2007). Recently, the first case report was published of a
patient with schizophrenia and medication-resistant AVH who
was successfully stimulated at the same region with transcranial
direct current stimulation (Homan et al., 2011), and this finding
has been confirmed by a larger study that used a slightly different
stimulation paradigm (Brunelin et al., 2012).
The present study conducted repeated measurements of psy-
chopathology and CBF. Our finding of persistent regional hyper-
perfusion in the left STG in AVH was consistent with a recent
meta-analysis that has suggested that neuronal activity in the
left STG is a trait marker in AVH (Kuhn and Gallinat, 2012).
That study classified neuroimaging studies that explored AVH in
state and trait studies. Symptom-catching state studies compare
periods of the presence of hallucinations with periods of the
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absence of hallucinations within subject, whereas trait studies
compare the brain activity between hallucinating subjects with
that of non-hallucinating patients with schizophrenia or healthy
controls. The findings in the meta-analysis have supported the
idea that AVH are caused by a permanent defective monitoring
of inner speech (trait) and a temporary misattribution of inter-
nally generated speech (state). State-like brain regions have been
consistently found in frontal speech-generating regions, whereas
the left temporal brain regions (left STG, left middle temporal
gyrus) have been found in trait studies. The alteration that was
found in these left temporal regions was less activation during
tasks involving verbal material-like inner speech generation or
prerecorded listening. However, the direction of this alteration
has been somewhat difficult to interpret because brain activity
is first compared on a within-subject basis, and this difference
is then contrasted between participants. This raised the ques-
tion of whether hallucinating patients could have tonically high
activity or tonically low activity that is independent of state (the
degree of subjectively experienced AVH) in the temporal lobe,
which would then contribute to the small differences that were
observed in the within-subject comparison between conditions
and to the seemingly decreased activation in hallucinating sub-
jects compared to non-hallucinating subjects (Kuhn and Gallinat,
2012). Thus, our findings of persistently increased CBF in the left
STG was in line with the suggestion of tonically high activity in
hallucinating patients and extends the proposed trait marker to
the confirmation of the increased hyperperfusion, at least for our
4 measurement time points.
Some limitations of our study design merit comment. No
direct relationship between brain activity and the occurrence of
hallucinations during scanning was investigated because, in ASL,
the mean cerebral perfusion was calculated over the scanning
time. Therefore, the temporal resolution was low. In addition, the
variance of the intervals between the measurements was certainly
a weakness of the present study. However, we took this variance
into account by including the intervals between measurements as
a fixed effect in the general linear mixed models that we com-
puted, and no effect was evident. In addition, ASL measured a
baseline CBF increase, which can be interpreted as a trait for
AVH. However, because we did not exactly know when during the
measurements that the patients were hallucinating, one cannot
exclude that this region also can show state-dependent behav-
ior like that previously described for the primary auditory cortex
(Dierks et al., 1999; Jardri et al., 2011; Kompus et al., 2011). As
long as a ceiling for neural activity for a certain region has not
been reached, a region with a higher baseline CBF can generate
additional neuronal activation. Finally, the small sample size has
to be considered. The study might thus have been underpowered
for detecting significant differences in the left STG CBF across
time.
In conclusion, this study showed that the regional CBF in the
left STG was tonically increased in patients with schizophrenia
and AVH, and this was consistent with what has previously been
termed a trait marker of AVH in schizophrenia.
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